Alireza Ghoreifi, MD
@alirezaghoreifi
@UroOnc Fellow @DukeUrology| @USC_Urology alumni| Social Media Editor @UrolOncol |@SIU_urology Innovators Committee| ECEB @Current_Urology ⚽️🎬🎼
Bladder, kidney, prostate—#WorldGU25 covers it all. And with Dr. @michaelabern on the faculty, you know you’re getting the latest from someone shaping the field. Aug 21–23 | Nashville, TN. CE-accredited. Multidisciplinary. Unmissable. 🎟️ Register now: hubs.la/Q03sgshd0…
In the era of EV plus pembro, where does radical cystectomy fit into treatment plans for patients with urothelial carcinoma? @siadaneshmand provides a detailed overview for #ASCODailyNews: brnw.ch/21wUqpv
Physicians, APPs, Nurses, Pharmacists: Don’t wait. #WorldGU25 is next month. Join 60+ experts in Nashville, TN, Aug 21–23 for cutting-edge education on prostate, bladder & kidney cancers—and earn up to 11.75 #CE credits. Register now: hubs.la/Q03wc2t90 #CME
📢New in @UrolOncol! Highlights: ▶️Lower preop step counts↔️dc to SNF ▶️Lower in-hospital activity↔️dc to SNF ▶️Lower preop calorie expenditure↔️longer LOS ❌No link between periop activity and complications or readmissions 🔗bit.ly/4kT3Qrn
Honored to be one of the @GUconference poster winners! Grateful to my mentor @michaelabern and our amazing team @JuddMoul @Davicioni @DukeGUCancer @DukeUrology
Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. hubs.la/Q03wLfxZ0…
🔥The August 2025 issue of 'Urologic Oncology: Seminars and Original Investigations' is now available. Unlock the latest in urologic oncology by following this link!🔗bit.ly/3GvpPq8 @UroOnc @SUO_YUO #NowOnline #UroSoMe #MedTwitter
Registry data shows risk migration with blue light cystoscopy. @alirezaghoreifi @DukeUrology & @siadaneshmand @KECKSchool_USC sit down with @UroDocAsh @MDAndersonNews to highlight the blue light cystoscopy registry's value as an ongoing real-world database with over 3,000…
In this video, @AnneSchuckmanMD outlines current challenges in NMIBC care urologytimes.com/view/anne-schu… #urology #bladdercancer @USC_Urology
New from the ROBUUST group in @Cancers_MDPI @FarshadSheybaee @Hoomandjaladat #UTUC #Immunotherapy 🔗Free link access: mdpi.com/2072-6694/17/1…
Nadofaragene firadenovec treatment updates for BCG-unresponsive #BladderCancer. @AnneSchuckmanMD @KeckMedicineUSC joins @UroDocAsh @MDAndersonNews discussing nadofaragene firadenovec's mature data, convenient dosing, and durable responses, changing the game for patient care.…
What a fantastic tool! Thanks for sharing. @KariTikkinen @GU_BigWhacks @saumyg @VigneshPackiam @UroAlsyouf @douglawi @LeileiXiaUro @alirezaghoreifi @domesypantsx3
🩸💥 Many have asked: “Where did the EAU #thromboprophylaxis guideline go?” Don’t worry. Check out cluevte.org 🚀 ✅ Not just #urology, also #gynecology & abd #surgery ✅ Procedure-specific VTE & bleeding risks ✅ Free interactive tool + static infographics #EBM
Should #radicalcystectomy ever be considered for consolidate therapy post EV/P?dailynews.ascopubs.org/do/personalizi… @PGrivasMDPhD @shilpaonc @tompowles1 @MattGalsky @OncBrothers @montypal @DrYukselUrun @nirajaiims @UroDocAsh @IBCG_BladderCA @SWOG @UroOnc @BladderCancerUS
🔥Our new video article has just been published in @JEndourology #Videourology @LiebertPub @AmirLebastchi @erikaloulou @USC_Urology #ProstateCancer #FocalTherapy 🔗liebertpub.com/doi/10.1089/vi…
A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend RIP Boss @UroOnc @AmerUrological
Important data on focal therapy for prostate cancer. 🎯 ☢️ 🤖 Great job as always @alirezaghoreifi @lorenzormc and @KanekoMasatomo @FocalSociety
🔥Just published in @BJUICompass ➡️112 salvage RRP (84 post-RT and 28 post-FT) 📈Hx of RT vs FT >> higher 90d complications 👍Better continence and potency in post-FT vs RT cases @lorenzormc @KanekoMasatomo @ALDCAbreu @USC_Urology 🔗bjui-journals.onlinelibrary.wiley.com/doi/full/10.10…
📘 Just published in European Urology: 🔄 The 2025 EAU Guidelines on UTUC are here! 🧬 Major updates include: • Revised risk stratification framework • New recommendations for kidney-sparing approaches in low-risk UTUC • Clarified indications for perioperative chemotherapy &…
Congratulations to @DukeUrology @UroOnc PD and my mentor, Dr. @michaelabern, on receiving the Faculty Teaching Award 🏅
Great job by my colleagues @FarshadSheybaee @RKSayyid and the ROBUUST collaborative group!
📢Publication alert! Highlights: 1⃣ypN+ #UTUC has worse OS vs pN+ 2⃣ypN0 and pN0 pts have similar OS 3⃣All ypN+ pts experience metastasis within 1 year 4⃣89% of ypN+ vs 39% of pN+ have nodal/regional or distant Mets as initial site of recurrence 🔗bit.ly/45peamO
Excited to see this special collection come together! If you're interested in contributing, feel free to DM/email me or @MazyarZahir
Thrilled to share that I’ll be leading a special collection as Guest Editor at the prestigious @TA_Urology journal! Huge thanks to @alirezaghoreifi for joining as Co-Guest Editor, and to my amazing mentor @siadaneshmand for encouraging me to apply. journals.sagepub.com/topic/collecti…